Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bupi Peiyuan Zhiqiu Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily in the management of conditions associated with "deficiency of spleen qi" according to TCM theory. It has been studied in combination with warm acupuncture for the treatment of allergic rhinitis, particularly in patients diagnosed with spleen qi deficiency[1][3]. The decoction is considered a multi-herb prescription, and while its exact composition may vary by practitioner or region, it typically includes herbs aimed at tonifying (strengthening) the spleen and replenishing vital energy (qi). The mechanism of action is based on TCM principles rather than specific molecular targets; it is believed to regulate immune function, reduce inflammation, and improve symptoms related to allergic rhinitis by restoring balance within the body.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bupi Peiyuan Zhiqiu Decoction.